Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia

NCT05542095 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study halted prematurely; IRB approval not obtained

Conditions

Olfactory Disorder
COVID-19

Interventions

DRUG: Simvastatin

Sponsor

Washington University School of Medicine

Collaborators

[object Object]